Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China flag China · Delayed Price · Currency is CNY
8.32
-0.01 (-0.12%)
At close: Feb 13, 2026

SHE:002566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
115.8571.48487.73343.26219.7287
Short-Term Investments
----30.08-
Trading Asset Securities
454.04459.67102.9859.8470.16-
Cash & Short-Term Investments
569.89531.15590.72403.11319.94287
Cash Growth
5.12%-10.08%46.54%25.99%11.48%355.44%
Accounts Receivable
211.47199.03198.53264254.84276.45
Other Receivables
20.4315.3611.7522.2339.6134.13
Receivables
231.89214.39210.28286.23294.45310.59
Inventory
1,6051,6261,6171,6031,5971,616
Other Current Assets
7.533.7513.3210.1710.5310.01
Total Current Assets
2,4152,3762,4312,3032,2222,223
Property, Plant & Equipment
425.6450.34483.66526.11501.49423.3
Long-Term Investments
0.0415.23----
Goodwill
1.911.911.911.911.911.91
Other Intangible Assets
109.45111.35114.18117.03119.96123.41
Long-Term Deferred Tax Assets
14.1813.1512.6214.215.217.87
Long-Term Deferred Charges
1.672.152.023.072.994.1
Other Long-Term Assets
16.140.761.271.681.042.16
Total Assets
2,9842,9713,0472,9672,8642,796
Accounts Payable
10.661324.8624.3319.8124.8
Accrued Expenses
5.2422.2632.5130.6848.1120.58
Short-Term Debt
348.23290.28470.43430.43397.86405.4
Current Portion of Long-Term Debt
4.020.42--2.5510
Current Portion of Leases
-2.982.343.293.31-
Current Income Taxes Payable
11.860.012.780.645.553.09
Current Unearned Revenue
8.525.4911.0124.5116.7241.47
Other Current Liabilities
26.531.5545.9174.2939.8469.18
Total Current Liabilities
415.04366589.85588.16533.75574.52
Long-Term Debt
129.7149.7---2.55
Long-Term Leases
5.116.214.039.8211.46-
Long-Term Unearned Revenue
106.99112.54118.69118.02120.8586.79
Long-Term Deferred Tax Liabilities
2.032.771.741.170.02-
Total Liabilities
658.86637.22714.3717.18666.08663.86
Common Stock
330.95330.95330.95330.95330.95330.95
Additional Paid-In Capital
834.69834.69834.69834.69834.69834.69
Retained Earnings
1,0611,0701,068989.34916.17830.08
Total Common Equity
2,2272,2362,2332,1552,0821,996
Minority Interest
98.1297.8399.2694.45116.47136.52
Shareholders' Equity
2,3252,3332,3322,2492,1982,132
Total Liabilities & Equity
2,9842,9713,0472,9672,8642,796
Total Debt
487.07449.59476.8443.55415.18417.95
Net Cash (Debt)
82.8281.56113.92-40.44-95.24-130.96
Net Cash Growth
27.37%-28.40%----
Net Cash Per Share
0.250.250.34-0.12-0.29-0.40
Filing Date Shares Outstanding
330.95330.95330.95330.95330.95330.95
Total Common Shares Outstanding
330.95330.95330.95330.95330.95330.95
Working Capital
2,0002,0101,8411,7141,6881,649
Book Value Per Share
6.736.766.756.516.296.03
Tangible Book Value
2,1152,1222,1172,0361,9601,870
Tangible Book Value Per Share
6.396.416.406.155.925.65
Buildings
-548.14548.14545.7400.71400.4
Machinery
-353.49359357.13321.57317.93
Construction In Progress
---1.98119.3227.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.